SCHEMBL19626588

SCHEMBL19626588

CCN(CC)c1cccc(-c2nc(C)sc2C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
CYP3A4 P08684 2/20 0.42
HPGD P15428 1/20 0.41
TERT O14746 1/20 0.39
HTR7 P34969 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
S100B P04271 1/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
GFER P55789 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625445 0.83 ALDH1A1 (0.39) ALDH1A1CYP3A4TERTHTR7PTGDR2
SCHEMBL2093695 0.76 ALDH1A1 (0.46) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL8202097 0.76 ALDH1A1 (0.49) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL17626245 0.75 ALDH1A1 (0.41) ALDH1A1CYP3A4TERTPTGDR2S100B
SCHEMBL19627010 0.73 GFER (0.59) ALDH1A1HPGDMAPTSMN1; SMN2HSD17B10
SCHEMBL2091654 0.73 KDM1A (0.48) ALDH1A1CYP3A4HPGDKMT2A
SCHEMBL13545723 0.73 ALDH1A1 (0.46) ALDH1A1HPGDMAPTSMN1; SMN2HSD17B10
SCHEMBL7946606 0.73 ALDH1A1 (0.49) ALDH1A1CYP3A4HPGDMAPTSMN1; SMN2
SCHEMBL9320596 0.71 ALDH1A1 (0.59) ALDH1A1CYP3A4HPGDTERTS100B
SCHEMBL2093741 0.71 ALDH1A1 (0.59) ALDH1A1HPGDHTR7MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885CYP3A4 419/4885HPGD 1547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.